Recent advancements in the B7/CD28 immune checkpoint families: new biology and clinical therapeutic strategies

MC Pulanco, AT Madsen, A Tanwar… - Cellular & Molecular …, 2023 - nature.com
The B7/CD28 families of immune checkpoints play vital roles in negatively or positively
regulating immune cells in homeostasis and various diseases. Recent basic and clinical …

HERVs and cancer—A comprehensive review of the relationship of human endogenous retroviruses and human cancers

E Stricker, EC Peckham-Gregory, ME Scheurer - Biomedicines, 2023 - mdpi.com
Genomic instability and genetic mutations can lead to exhibition of several cancer hallmarks
in affected cells such as sustained proliferative signaling, evasion of growth suppression …

[HTML][HTML] KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: the dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer …

Y Li, C Lv, Y Yu, B Wu, Y Zhang, Q Lang, Z Liang… - Journal of advanced …, 2023 - Elsevier
Background T cells and natural killer (NK) cells are essential components of the immune
system and are regulated by coinhibitory and costimulatory molecules in which the B7 family …

CancerHERVdb: human endogenous retrovirus (HERV) expression database for human cancer accelerates studies of the retrovirome and predictions for HERV …

E Stricker, EC Peckham-Gregory… - Journal of …, 2023 - Am Soc Microbiol
In this study, we sought to create a database summarizing the expression of human
endogenous retroviruses (HERVs) in various human cancers. HERVs are suitable …

Clinical significance of the HHLA2 protein in hepatocellular carcinoma and the tumor microenvironment

M Luo, Y Lin, R Liang, Y Li, L Ge - Journal of Inflammation …, 2021 - Taylor & Francis
Background The protein “human endogenous retrovirus H long terminal repeat-associating
2”(HHLA2), a member of the B7 family, has been linked to cancer progression and immune …

Human endogenous retrovirus-H long terminal repeat-associating 2: The next immune checkpoint for antitumour therapy

H Ying, J Xu, X Zhang, T Liang, X Bai - EBioMedicine, 2022 - thelancet.com
Human endogenous retrovirus-H long terminal repeat-associating 2 (HHLA2) is a newly
emerging immune checkpoint that belongs to B7 family. HHLA2 has a co-stimulatory …

The expression and function of the B7 family in Helicobacter pylori infection and gastric carcinogenesis process

Y Zhang, Z Zhao, W Fu, S Ding - Helicobacter, 2023 - Wiley Online Library
Background The B7 protein family is one of the most important immune checkpoint proteins.
Gastric cancer (GC) is the fourth most common cause of cancer‐related mortality worldwide …

[HTML][HTML] B7-H7: A potential target for cancer immunotherapy

Q Su, J Du, X Xiong, X Xie, L Wang - International Immunopharmacology, 2023 - Elsevier
Cancer immunotherapy enhances the body's immunity against tumors by mitigating immune
escape. Compared with traditional chemotherapy, immunotherapy has the advantages of …

The Importance of HHLA2 in Solid Tumors—A Review of the Literature

A Kula, D Koszewska, A Kot, M Dawidowicz… - Cells, 2024 - mdpi.com
Cancer immunotherapy is a rapidly developing field of medicine that aims to use the host's
immune mechanisms to inhibit and eliminate cancer cells. Antibodies targeting CTLA-4, PD …

[HTML][HTML] Evaluation of HHLA2 and CD8 Immunohistochemical Expression in Colorectal Carcinoma and Their Prognostic Significance

ZM Gawesh, EM Ibrahim, HMHR ElKalla… - Asian Pacific Journal …, 2023 - ncbi.nlm.nih.gov
Background: Colorectal carcinoma (CRC) is the third most common malignancy worldwide.
Human endogenous retrovirus H long terminal repeat-associating protein 2 (HHLA2) is a …